S058 Psoriasis: Modern Therapeutic Approaches
DESCRIPTION
This is a comprehensive overview of the latest information related to psoriasis and its therapy. A review of the updated psoriasis treatment guidelines from the AAD-NPF will be covered. An emphasis will be on oral and biologic therapies, treatment of mild-to-moderate psoriasis and special areas, the comorbidities of psoriasis, and the impact of therapy on those comorbidities.
This session will provide an opportunity to review and apply some time-honored strategies, as well as a few new ones, to the factors that make our lives feel out of control. This activity has been approved by the American Board of Dermatology (ABD) for up to 30 Continuous Certification Program (CCP) Component 2 Self-Assessment points. For more information about CCP, please visit the ABD website at www.abderm.org
LEARNING OBJECTIVES
Measure the effects of modern therapies on the comorbidities associated with psoriasis.
Describe the treatment approach to psoriasis regardless of body surface area of involvement, and understand the impact of special areas of involvement on quality of life.
Differentiate the use of modern oral therapies for psoriasis and their placement in the treatment arsenal.
SCHEDULE
9:00 AM
Update on Pipeline Therapies for Psoriasis
Bruce Elliot Strober, MD, PhD, FAAD
9:20 AM
Early Treatment Of Psoriasis: A Window of Opportunity?
Richard G. B. Langley, MD, FAAD
9:40 AM
Impact of Comorbidities on Biologic Selection for Psoriasis
Jeffrey Marcus Cohen, MD, FAAD
10:00 AM
Clinical consideration in managing women with psoriasis
Jennifer Soung, MD, FAAD
10:20 AM
Comparative efficacy and relative ranking of psoriasis biologics using real world and clinical trial data
Mona Shahriari, MD, FAAD
10:40 AM
Translating AAD/NPF guidelines to your clinical practice to lower cardiovascular risk in patients with psoriasis
Joel M. Gelfand, MD, MSCE, FAAD
11:00 AM
Treating psoriasis while preventing psoriatic arthritis: What are the early data?
Kenneth B. Gordon, MD, FAAD
11:20 AM
Q&A
DIRECTOR
Bruce Elliot Strober, MD, PhD, FAAD
SPEAKERS
Jeffrey Marcus Cohen, MD, FAAD
Joel M. Gelfand, MD, MSCE, FAAD
Kenneth B. Gordon, MD, FAAD
Richard G. B. Langley, MD, FAAD
Mona Shahriari, MD, FAAD
Jennifer Soung, MD, FAAD
HANDOUTS
DISCLOSURES
Jeffrey Marcus Cohen, MD, FAAD
Advarra – Data Safety Monitoring Board(Fees); GlaxoSmithKline Immunology – Consultant (1099 relationship)(Honoraria); Imagene Bio – Consultant (1099 relationship)(Honoraria); Johnson & Johnson – Advisory Board(Honoraria); JORA Immunology – Founder(Stock); Logical Images, Inc – Consultant(Honoraria); Novartis – Consultant (1099 relationship)(Fees); Sanofi – Consultant (1099 relationship)(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria);
Joel M. Gelfand, MD, MSCE, FAAD
AbbVie – Consultant(Fees); Alumis – Consultant (1099 relationship)(Fees); Alyson Oliver Partner & Attorney – Consultant (1099 relationship)(Fees); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees); Arnold & Porter – Consultant (1099 relationship)(Fees); Boehringer Ingelheim – Consultant (1099 relationship)(Fees); Bristol Myers Squibb – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); FIDE – Consultant(Fees); Healio – Other(Fees); Inmagene Biopharmaceuticals – Data Safety Monitoring Board(Fees); International Psoriasis Council – Board of Directors(No Compensation Received); Johnson & Johnson Innovative Medicine – Consultant (1099 relationship)(Fees); Leo Pharma Inc – Consultant(Fees); Maui Derm – Speaker/Faculty Education(Fees); Medical Dermatology Society – Board of Directors(No Compensation Received); Moonlake – Data Safety Monitoring Board(Fees); National Psoriasis Foundation – Investigator(Grants/Research Funding); Neuroderm LTD – Other(Fees); Oruka Therapeutics – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant (1099 relationship)(Fees);
Kenneth B. Gordon, MD, FAAD
AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding); Almirall – Consultant(Honoraria); Amgen – Consultant(Honoraria); Arcutis, Inc. – Consultant(Honoraria); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Honoraria); Dermavant Sciences – Consultant(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); Incyte Corporation – Consultant(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Leo Pharma Inc – Consultant(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria); Othro Dermatologics – Consultant(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Protagonist Therapeutics – Consultant (1099 relationship)(Honoraria); Sanofi Genzyme – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); UCB – Consultant(Honoraria);
Richard G. B. Langley, MD, FAAD
AbbVie – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Amgen – Investigator(Grants/Research Funding), Speaker(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Celgene Corporation – Advisory Board(Honoraria); Centocor Ortho Biotech Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Honoraria); Genentech, Inc. – Investigator(Grants/Research Funding); LEO Laboratories Ltd (LEO Pharma) – Investigator(Grants/Research Funding); Merck Serono – Investigator(Grants/Research Funding); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding), Speaker(Honoraria); UCB – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Mona Shahriari, MD, FAAD
AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Amgen – Consultant (1099 relationship)(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Arcutis Biotherapeutics – Speaker(Honoraria); Bristol-Myers Squibb – Speaker(Honoraria); CoreEvitas, LLC – Advisory Board(Honoraria), Investigator(Fees); Dermavant Sciences – Investigator(Grants/Research Funding), Speaker(Honoraria); Eli Lilly and Company – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Galderma – Advisory Board(Honoraria), Speaker(Honoraria); Incyte Corporation – Advisory Board(Honoraria); Janssen Biotech – Consultant(Honoraria), Speaker/Faculty Education(Honoraria); LEO Pharma, US – Consultant(Honoraria), Speaker/Faculty Education(Honoraria); National Psoriasis Foundation – Speaker/Faculty Education(Honoraria); Novartis – Consultant(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Sanofi/Regeneron – Consultant(Honoraria), Speaker(Honoraria); UCB – Consultant(Honoraria), Speaker(Honoraria);
Jennifer Soung, MD, FAAD
AbbVie – Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Alumis – Investigator(Grants/Research Funding); Amgen – Speaker(Honoraria); Arcutis, Inc. – Consultant(Honoraria); ASLAN Pharmaceuticals – Investigator(Grants/Research Funding); Boehringer Ingelheim – Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Bristol Myers Squibb – Consultant (1099 relationship)(Honoraria); Dermavant Sciences – Consultant(Fees), Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Evelo Biosciences, Inc. – Advisory Board(Honoraria); Galderma USA – Investigator(Grants/Research Funding); Incyte – Consultant (1099 relationship)(Honoraria); Incyte Corporation – Speaker/Faculty Education(Honoraria); Janssen Biotech – Investigator(Grants/Research Funding), Speaker(Honoraria); Kobio Labs – Investigator(Fees); LEO Laboratories Ltd (LEO Pharma) – Advisory Board(Honoraria), Investigator(Grants/Research Funding); LEO Pharma, US – Speaker/Faculty Education(Honoraria); National Psoriasis Foundation – Speaker/Faculty Education(Honoraria); Novartis – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Ortho Dermatologics – Consultant(Honoraria), Speaker(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding), Speaker(Honoraria); Regeneron – Speaker(Honoraria); Sanofi Genzyme – Speaker(Honoraria); UCB – Consultant(Honoraria), Investigator(Grants/Research Funding);
Bruce Elliot Strober, MD, PhD, FAAD
AbbVie – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); Alumis – Consultant(Fees); Amgen – Consultant (1099 relationship)(Fees); Arcutis, Inc. – Consultant(Fees), Speaker(Honoraria); Boehringer Ingelheim – Consultant(Honoraria); Bristol Myers Squibb – Speaker(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees); Connect Biopharma LLC – Stockholder(Other Financial Benefit); CoreEvitas, LLC – Advisory Board(Honoraria), Investigator(Fees); Eli Lilly and Company – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); Johnson and Johnson – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees), Speaker(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria), Consultant(Honoraria); Meiji Seika Pharma Co., Ltd – Consultant(Fees); Mindera – Stockholder(Other Financial Benefit); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria), Consultant(Honoraria); Oruka Therapeutics – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); UCB – Advisory Board(Honoraria), Consultant(Fees), Speaker(Honoraria);